Literature DB >> 2156488

Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease.

F Vlaspolder1, T A Oosterlaken, M Harmsen, P W van Dijk, H Kievit, C A Kraaijeveld, H Snippe.   

Abstract

Monoclonal antibodies (MA) UM 21.1 and UM 21.2 protect mice against encephalomyocarditis virus (D-variant) induced diabetes and lethal disease. MA-mediated protection in vivo as well as neutralization in vitro could be specifically blocked by anti-idiotypic antibodies.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2156488     DOI： 10.1007/BF01311296

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  13 in total

1.  SOME PROPERTIES OF THE ENCEPHALOMYOCARDITIS, COLUMBIA SK AND MENGO VIRUSES.

Authors:  J E CRAIGHEAD
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

Review 2.  The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus.

Authors:  J E Craighead
Journal:  Prog Med Virol       Date:  1975

3.  Virus-induced diabetes mellitus. III. Influence of the sex and strain of the host.

Authors:  D W Boucher; K Hayashi; J Rosenthal; A L Notkins
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

4.  Genetic differences in susceptibility of pancreatic beta cells to virus-induced diabetes mellitus.

Authors:  J W Yoon; M A Lesniak; R Fussganger; A L Notkins
Journal:  Nature       Date:  1976-11-11       Impact factor: 49.962

Review 5.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06

6.  Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon.

Authors:  F Vlaspolder; T Harmsen; D van Veenendaal; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

7.  Discrimination of determinant specificity of two encephalomyocarditis virus neutralizing monoclonal antibodies by competition, mixed neutralization and anti-idiotypic antibodies.

Authors:  F Vlaspolder; C A Kraaijeveld; T Oosterlaken; R van Buuren; B J Benaissa-Trouw; H Snippe
Journal:  J Virol Methods       Date:  1988-05       Impact factor: 2.014

8.  Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus.

Authors:  C A Kraaijeveld; G la Rivière; B J Benaissa-Trouw; J Jansen; T Harmsen; H Snippe
Journal:  Antiviral Res       Date:  1983-09       Impact factor: 5.970

9.  Helper-inducer T-lymphocytes mediate diabetes in EMC-infected BALB/c ByJ mice.

Authors:  M K Haynes; S A Huber; J E Craighead
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

10.  Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.